Hyperhidrosis: A new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey

International Journal of Clinical Practice

Volumn 60, Issue 9, 2006, Pages 1053-1059

  Lidove, Oliver ^a   Ramaswami, U ^b,c   Jaussaud, R ^c,c   Barbey, F ^c,d   Maisonobe, T ^e   Caillaud, C ^f   Beck, M ^c,g   Sunder Plassmann, G ^c,h   Linhart, A ^c,i   Mehta, A ^c,j   Bodamer, O ^c   Hauser, A C ^c   Kleinert, J ^c   Binder, C ^c   Kotanko, P ^c   Kroepfl, T ^c   Plecko, B ^c   Clerbaux, G ^c   Georges, B ^c   Nassogne, M C ^c   Pirson, Y ^c   Dehout, F ^c   Roland, D ^c   Van Maldergem, L ^c   Goyens, P ^c   De Smet, K ^c   Eyskens, F ^c   Bultas, J ^c   Karetova D ^c   Lubanda, J C ^c   Magage, S ^c   Choukroun, G ^c   Berthelot, J ^c   Carey Reomonnay, S ^c   Lacombe, D ^c   Benziane, S ^c   Hachulla, E ^c   Dussol, B ^c   Jaeger, P ^c   Germain, D ^c   Lidove, O ^c   Caraman, D ^c   von Arnim Baas, A ^c   Hennermann, J ^c   Neumann, H P H ^c   Das, A ^c   Illsinger, S ^c   Baron, K ^c   Delgado Sanchez S ^c   Hartung, R ^c   Kampmann, C ^c   Kim, K S ^c   Schwarting, A ^c   Tremmel, H ^c   Whybra, C ^c   Hoffmann, B ^c   Koletzko, B ^c   Bottcher T ^c   Rolfs, A ^c   Gabrielli, O ^c   Salvatori, I F ^c   Borsini, W ^c   Buchner, S ^c   Parini, R ^c   Ravaglia, R ^c   Santus, F ^c   Di Vito, R ^c   Gasbarri, C ^c   Burlina, A ^c   Tognana, G ^c   Antuzzi, D ^c   Catorina, M ^c   Di Lillo, M ^c   Feriozzi, S ^c   Ricci, R ^c   Bindoff, L A ^c   Bostad, L H ^c   Grant, A L ^c   Haugen, O H ^c   Hirth, A ^c   Houge, G ^c   Kaarboe O ^c   Laegreid L M ^c   Neckelmann, G ^c   Stromsvik N ^c   Svarstad, E ^c   Thune, T J ^c   Tondel C ^c   Skarbovik A ^c   Tafjord, A B ^c   Barba, M A ^c   Gomez Huertas E ^c   Herrera, J ^c   Ara, J ^c   Bonal, J ^c   Larrousse, E ^c   Pintos, G ^c   Ballarin, J ^c   Torra, R ^c   Torras, J ^c   Torregrosa, V ^c   Gonzalez J ^c   Garcia, M ^c   Herrera, C ^c   Martin, I ^c   Rodriguez, J ^c   Barbado, F J ^c   Garcia Consuegra, J ^c   Garcia de Lorenzo, A ^c   Lopez M ^c   Paniagua, J ^c   Hernandez S ^c   Fernandez V ^c   Leon A ^c   Andreu, J ^c   Leon J A ^c   Maya, E ^c   Febrer, I ^c   Perez Garcia A ^c   Rivera, A ^c   Oqvist B ^c   Huynh Do, U ^c   Theytaz, J ^c   Schulthess, G ^c   Walter, K ^c   Widmer, U ^c   Cox, T M ^c   Deegan, P ^c   Wright, N ^c   Burns, A ^c   Elliott, J ^c   Elliott, P M ^c   Evans, S ^c   Ginsberg, L ^c   Hughes, D ^c   Ionedes, A ^c   Milligan, A ^c   Orteu, C ^c   Richfield, L ^c   Shah, J ^c   more..

^a BICHAT HOSPITAL   (France)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c Robert DebréHospital ^*

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f Cochin Hospital ^*  (France)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j ROYAL FREE HOSPITAL   (United Kingdom)

more..

Author keywords

Early diagnosis; Fabry disease; Fabry Outcome Survey; Heterozygote; Hyperhidrosis

Indexed keywords

AGALSIDASE ALFA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENCE; ADULT; AGED; ARTICLE; CHILD; CHILDHOOD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; ENZYME REPLACEMENT; EUROPE; FABRY DISEASE; FEMALE; HEMIZYGOTE; HETEROZYGOTE; HUMAN; HYPERHIDROSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FABRY DISEASE; FEMALE; HUMANS; HYPERHIDROSIS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 33747191418     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01061.x     Document Type: Article

References (28)

1. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. J Am Med Assoc 1999; 281: 249-54.
2. Houge G, Skarbovik AJ. [Fabry disease - a diagnostic and therapeutic challenge]. Tidsskr Nor Laegeforen 2005; 125: 1004-6.
3. Peters FP, Vermeulen A, Kho TL. Anderson-Fabry's disease: alpha-galactosidase deficiency. Lancet 2001; 357: 138-40.
4. Ries M, Ramaswami U, Parini R et al. The early clinical phenotype of Fabry disease: A study on 35 European children and adolescents. Eur J Pediatr 2003; 162: 767-72.
5. Mehta A, Ricci R, Widmer U et al. Fabry disease defined: Baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 2004; 34: 236-42.
6. Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: Evidence of genetic transmission. J Vasc Surg 2002; 35: 382-6.
7. Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004; 51: 241-8.
8. Mohrenschlager M, Braun-Falco M, Ring J, Abeck D. Fabry disease: recognition and management of cutaneous manifestations. Am J Clin Dermatol 2003; 4: 189-96.
9. Lao LM, Kumakiri M, Mima H et al. The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis. J Dermatol Sci 1998; 18: 109-17.
10. Tan SV, Lee PJ, Walters RJ, Mehta A, Bostock H. Evidence for motor axon depolarization in Fabry disease. Muscle Nerve 2005; 32: 548-51.
11. Freeman R. Autonomic peripheral neuropathy. Lancet 2005; 365: 1259-70.
12. Mutoh T, Senda Y, Sugimura K et al. Severe orthostatic hypotension in a female carrier of Fabry's disease. Arch Neurol 1988; 45: 468-72.
13. Cable WJ, Kolodny EH, Adams RD. Fabry disease: Impaired autonomic function. Neurology 1982; 32: 498-502.
14. Burda CD, Winder PR. Angiokeratoma corporis diffusum universale (Fabry's disease) in female subjects. Am J Med 1967; 42: 293-301.
15. Galanos J, Nicholls K, Grigg L, Kiers L, Crawford A, Becker G. Clinical features of Fabry's disease in Australian patients. Intern Med J 2002; 32: 575-84.
16. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: Clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001; 38: 769-75.
17. Gupta S, Ries M, Kotsopoulos S, Schiffmann R. The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women. Medicine (Baltimore) 2005; 84: 261-8.
18. Whybra C, Kampmann C, Willers I et al. Anderson-Fabry disease: Clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 2001; 24: 715-24.
19. Grunfeld JP, Lidove O, Barbey F. Heterozygotes with Fabry's disease. Contrib Nephrol 2001; 136: 208-10.
20. Miners AH, Holmes A, Sherr L, Jenkinson C, MacDermot KD. Assessment of health-related quality-of-life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 2002; 11: 127-33.
21. Gold KF, Pastores GM, Botteman MF et al. Quality of life of patients with Fabry disease. Qual Life Res 2002; 11: 317-27.
22. Desnick RJ, Ioannou YA, Eng CM. α -Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases, 8th edn. New York: McGraw-Hill 2001, pp. 3733-74.
23. Morgan SH, Crawfurd MA. Anderson-Fabry disease. Br Med J 1988; 297: 872-3.
24. Mehta AB, Lewis S, Laverey C. Treatment of lysosomal storage disorders. Br Med J 2003; 327: 462-3.
25. Baumann LS, Halem ML. Botulinum toxin-B and the management of hyperhidrosis. Clin Dermatol 2004; 22: 60-5.
26. Eisenach JH, Atkinson JL, Fealey RD. Hyperhidrosis: Evolving therapies for a well-established phenomenon. Mayo Clin Proc 2005; 80: 657-66.
27. Herbst F, Plas EG, Fugger R, Fritsch A. Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs. A critical analysis and long-term results of 480 operations. Ann Surg 1994; 220: 86-90.
28. Schiffmann R, Floeter MK, Dambrosia JM et al. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 2003; 28: 703-10.